CHARLES SCHWAB INVESTMENT MANAGEMENT INC - CYTOSORBENTS CORP ownership

CYTOSORBENTS CORP's ticker is CTSO and the CUSIP is 23283X206. A total of 95 filers reported holding CYTOSORBENTS CORP in Q4 2020. The put-call ratio across all filers is 1.49 and the average weighting 0.1%.

Quarter-by-quarter ownership
CHARLES SCHWAB INVESTMENT MANAGEMENT INC ownership history of CYTOSORBENTS CORP
ValueSharesWeighting
Q3 2023$30,069
-49.2%
15,994
-3.0%
0.00%
Q2 2023$59,213
+9.9%
16,494
+3.1%
0.00%
Q1 2023$53,900
+117.4%
15,9940.0%0.00%
Q4 2022$24,791
+12.7%
15,9940.0%0.00%
Q3 2022$22,000
-38.9%
15,9940.0%0.00%
Q2 2022$36,000
-89.3%
15,994
-84.9%
0.00%
Q1 2022$338,000
-23.4%
105,693
+0.5%
0.00%
Q4 2021$441,000
-47.2%
105,131
+2.2%
0.00%
Q3 2021$836,000
+7.0%
102,878
-0.5%
0.00%
Q2 2021$781,000
-13.9%
103,396
-1.0%
0.00%
Q1 2021$907,000
+12.3%
104,392
+3.1%
0.00%
Q4 2020$808,000
+6.6%
101,279
+6.6%
0.00%
Q3 2020$758,000
-9.0%
94,994
+13.0%
0.00%
Q2 2020$833,000
+32.6%
84,080
+3.6%
0.00%
Q1 2020$628,000
+100.6%
81,1810.0%0.00%
Q4 2019$313,000
-28.4%
81,181
-6.5%
0.00%
Q3 2019$437,000
-18.8%
86,864
+6.9%
0.00%
Q2 2019$538,000
+14.7%
81,270
+31.4%
0.00%
Q1 2019$469,000
-8.2%
61,831
-2.1%
0.00%
Q4 2018$511,000
-36.6%
63,153
+1.2%
0.00%
-100.0%
Q3 2018$806,000
+18.2%
62,424
+4.4%
0.00%
Q2 2018$682,00059,7970.00%
Other shareholders
CYTOSORBENTS CORP shareholders Q4 2020
NameSharesValueWeighting ↓
Sargent Investment Group, LLC 692,738$5,524,0002.01%
Skylands Capital, LLC 1,421,700$11,345,0001.89%
SECTORAL ASSET MANAGEMENT INC 1,629,989$12,999,0001.12%
Winning Points Advisors, LLC 286,200$1,142,990,0000.97%
Redmile Group, LLC 2,101,131$16,757,0000.31%
Granahan Investment Management 632,035$5,040,0000.17%
Avenir Corp 190,240$1,517,0000.16%
Seelaus Asset Management LLC 20,000$160,0000.13%
Olympiad Research LP 17,816$142,0000.07%
HighMark Wealth Management LLC 10,000$80,0000.07%
View complete list of CYTOSORBENTS CORP shareholders